Clinical analysis of non-blood transfusion treatment in patients who refused a blood transfusion for obstetrical part.
- Author:
Seung Jun PARK
1
;
Ji Young KIM
;
Seung Hee AN
;
Mi Kyung KIM
;
Sang Heon CHA
;
Kyu Yeon CHOI
;
Jeong Jae LEE
;
Im Soon LEE
Author Information
1. Department of Obstetrics and Gynecology, College of Medicine, Soonchunhyang University, Seoul, Korea. mkkim@hosp.sch.ac.kr
- Publication Type:Original Article
- Keywords:
Patients who refused a blood transfusion;
Obstetric hemorrhage;
Non-blood transfusion treatment
- MeSH:
Acute Kidney Injury;
Aprotinin;
Batroxobin;
Blood Transfusion;
Blood Transfusion, Autologous;
Cesarean Section;
Dacarbazine;
Erythropoietin;
Female;
Hemoglobins;
Hemorrhage;
Hospitalization;
Humans;
Obstetrics;
Pregnancy;
Retrospective Studies;
Uterine Inertia
- From:Korean Journal of Obstetrics and Gynecology
2008;51(1):82-88
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The goal of this study is to analyze the clinical manifestation of obstetrical patients who refused transfusion of any blood component. Through this analysis, we could define the guideline of non-blood transfusion treatment during the obstetrical procedure. METHODS: 127 patients who visited our non-blood transfusion treatment center and had obstetrical procedures from 1 Jan. 2000 to 31 March 2006 participated in this study. They were retrospectively analyzed according to the following indexes; the reason of refusing blood transfusion, age, ratio of vaginal delivery to Cesarean section, comparison of hemoglobin level, volume of blood loss, presence of bloodless treatment, days of hospitalization, presence of blood transfusion, consequence of patient (including complications and deaths). Bloodless treatment at the hospital are medical method (recombinant human erythropoietin, Aprotinin, Hemocoagulase, Tranexamine acid, Venoferrum), Autotransfusion and Electrocauterization. RESULTS: Among 126 patients (except for 1 patient who was delivered at the other hospital), the vaginal delivery group consisted of 57, and the Cesarean operation group was 69. The most common cause of primary caesarean section was arrest disorder of cephalo-pelvic disproportion. Among 26 patients qualified for indication of transfusion, uterine atony had the highest number of patients at 16. Among the indication of transfusion, low hemoglobin level (< or =8.0 g/dL) after operation had the highest number of patients at 20. Patients qualified indication of transfusion had twice more blood loss (464.6+/-34.2 ml vs 920.5+/-214.2 ml) and two more days of hospitalization (7.6+/-0.5 day vs 9.7+/-0.6 day) compared with those of non-qualified for indication of transfusion. Nobody received direct transfusion of blood component. There were no death but acute renal failure in one patient, and DIC (disseminated intravascular coagulation) in another patient as complications. CONCLUSIONS: This study analyzed the clinical manifestations of patients who refused a blood transfusion in obstetrics. Especially, when the non-blood transfusion treatment was performed, which had been an issue in recent times, more active treatment showed less reduction of hemoglobin level than no treatment. This study also confirmed that bleeding patients can be treated by selective non-blood transfusion treatment.
